MACE INDUSTRIES LIMITED

Financial Health Score: A

Mace Industries Limited exhibits an excellent state of financial wellness. With a strong liquidity position, virtually no long-term debt, and consistent retained profitability, the company is in robust health. The only minor symptom of note is a slight contraction in cash reserves, but this is easily explained by healthy capital investment and the settling of prior obligations.

1. Key Vital Signs

• Pulse (Liquidity & Working Capital): The company’s current ratio stands at a very healthy 2.81:1 (Current Assets of £6.48M vs. Current Liabilities of £2.3M). This indicates a strong, steady financial heartbeat, meaning the business has almost £3 of short-term assets for every £1 of short-term liabilities due. Net current assets (working capital) are a robust £4.17 million.
• Blood Pressure (Leverage & Debt): Total liabilities (£2.3M) represent roughly 32.7% of total assets (£7M). More importantly, the balance sheet shows no long-term creditors. The business is operating with very low financial blood pressure—meaning it is not straining under the weight of heavy debt or risky loan covenants.
• Respiration (Cash Flow): Cash "breathing" remains strong at £1.66 million. While this is down from the previous period's £2.02 million, the reduction is not a symptom of distress but rather a sign of the business exhaling cash to settle trade creditors and invest in fixed assets (plant & machinery additions of £256k).
• Weight (Asset Base & Equity): Net assets have grown to £4.73 million (up from £4.16 million), and the Profit and Loss reserve has increased by over £570k to £4.11 million. The business is gaining healthy financial weight through retained earnings rather than artificial bloating from debt.

2. Diagnosis

The patient is in outstanding physical condition. Mace Industries is displaying classic signs of a mature, well-managed, and profitable family enterprise.

The most recent filing covers an 18-month period (November 2023 to April 2025), during which the business increased its retained profits substantially. Trade debtors have decreased (from £2.28M to £1.53M), suggesting the business has been highly effective at collecting money owed by customers. Simultaneously, trade creditors dropped significantly (from £2.57M to £1.12M), indicating the business has deliberately chosen to pay down its suppliers, clearing its financial arteries.

The complete absence of long-term debt and the fully amortized goodwill mean the business carries minimal legacy risk. The only slight anomaly is the drop in employee headcount from 49 to 48, which is negligible and likely represents natural attrition rather than a symptom of cost-cutting. Ultimately, the underlying business health is highly resilient.

3. Recommendations

While the patient is in fine fettle, even healthy individuals can benefit from a targeted wellness plan to ensure long-term vitality:

• Cardiovascular Workout (Strategic Leverage): With zero long-term debt and a cash-rich balance sheet, the business has immense financial capacity. Much like a patient with a resting heart rate that is too low, being overly conservative can limit peak performance. The directors should consider whether taking on a measured amount of long-term financing could fund expanded manufacturing capacity, R&D, or market expansion, leveraging their strong equity base to accelerate growth.
• Cholesterol Check (Inventory Management): Stock levels remain steady at just under £2M. Given that this represents roughly 28% of total assets, it is important to keep this "dietary intake" moving. Ensure that stock turn rates remain high and that ageing inventory does not become sluggish, tying up unnecessary cash.
• Vitamin Boost (Cash Yield): With over £1.6M sitting in the bank, ensure this cash is working as hard as possible. While retaining a healthy buffer is essential for operational peace of mind, surplus cash should be placed in high-yield business deposit accounts or short-term instruments to combat the effects of inflation, ensuring the company's financial immune system remains robust.